The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survivors and gilteritinib safety beyond one year in FLT3-mutated R/R AML: ADMIRAL trial follow-up.
 
Alexander E. Perl
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Astellas Pharma; Daiichi Sankyo; Jazz Pharmaceuticals; Newlink Genetics; Novartis; Takeda
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Arog; Astellas Pharma; Daiichi Sankyo; FORMA Therapeutics
Research Funding - Actinium Pharmaceuticals (Inst); Astellas Pharma (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Daiichi Sankyo (Inst); Fujifilm (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Agios; Arog; Astellas Pharma; Daiichi Sankyo; Jazz Pharmaceuticals; Newlink Genetics; Novartis; Takeda
 
Giovanni Martinelli
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Incyte; Jazz Pharmaceuticals; Pfizer; Roche
Speakers' Bureau - Jazz Pharmaceuticals; Menarini; Novartis
Research Funding - Daiichi Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; Daiichi Sankyo; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Pfizer
 
Andreas Neubauer
Speakers' Bureau - Medupdate
 
Ellin Berman
Consulting or Advisory Role - Astellas Pharma; Takeda
 
Maria R. Baer
Research Funding - Abbvie (Inst); AI Therapeutics (Inst); FORMA Therapeutics (Inst); Kite, a Gilead company (Inst); Oscotec (Inst); Takeda (Inst)
 
Richard A. Larson
Consulting or Advisory Role - Abbvie; Agios; Amgen; ARIAD; Astellas Pharma; Boston Biomedical; Celgene; Curis; CVS Caremark; DAVA Pharmaceuticals; ERYTECH Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Novartis (Inst); Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - UpToDate
 
Amir Tahmasb Fathi
Honoraria - DAVA Pharmaceuticals
Consulting or Advisory Role - Agios; Astellas Pharma; Boston Biomedical; Celgene; Clear Creek Bio; Daiichi Sankyo; Jazz Pharmaceuticals; Newlink Genetics; Novartis; PTC Therapeutics; Takeda
Research Funding - agios (Inst); Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
 
Hisayuki Yokoyama
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Astellas Pharma
Research Funding - Astellas Pharma
 
Naoko Hosono
No Relationships to Disclose
 
Nahla Hasabou
Employment - Astellas Pharma
 
Qiaoyang Lu
Employment - Astellas Pharma
 
Erkut Bahceci
Employment - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Astellas Pharma